Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering.

Gerhardt LC, Boccaccini AR. · 2010

Read Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering. by Gerhardt LC, Boccaccini AR. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5445790.txt.

Introduction

Gerhardt and Boccaccini review bioactive glass scaffolds for growing new bone. Their review appeared in Materials. Bioactive glasses bond directly to living bone. A bone-like mineral layer forms at the surface. The classic mix, 45S5 Bioglass, dates to a 1969 discovery. Such glasses once served as simple defect fillers. Tissue engineers now shape them into porous scaffolds. Cells can grow through the pores.

The review starts with the field's history and scaffold needs. It then surveys melt-derived silicate glasses and glass-ceramics. Common making methods get a full rundown. Structure is tied to strength and function. The authors compare scaffold traits with real human bone. Dissolving glass releases silicon, calcium, and other ions. Those ions can spur bone growth and vessel growth. Composite builds that mix glass with polymers also feature. The authors end by marking open research paths.

Catalog record

CREATORGerhardt LC, Boccaccini AR.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE119 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5445790

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering By Lutz-Christian Gerhardt, Aldo R Boccaccini Published in: Materials DOI: 10.3390/ma3073867 ABSTRACT Abstract Traditionally, bioactive glasses have been used to fill and restore bone defects. More recently, this category of biomaterials has become an emerging research field for bone tissue engineering applications. Here, we review and discuss current knowledge on porous bone tissue engineering scaffolds on the basis of melt-derived bioactive silicate glass compositions and relevant composite structures. Starting with an excerpt on the history of bioactive glasses, as well as on fundamental requirements for bone tissue engineering scaffolds, a detailed overview on recent developments of bioactive glass and glass-ceramic scaffolds will be given, including a summary of common fabrication methods and a discussion on the microstructural-mechanical properties of scaffolds in relation to human bone (structure-property and structure-function relationship). In addition, ion release effects of bioactive glasses concerning osteogenic and angiogenic responses are addressed. Finally, areas of future research are highlighted in this review. Keywords: bioactive glasses, glass-ceramics, melt-derived glasses, scaffolds, bone, tissue engineering, composites, ion release, osteogenesis, angiogenesis 1. INTRODUCTION Tissue engineering (TE) and regenerative medicine aim to restore diseased or damaged tissue using combinations of functional cells and biodegradable scaffolds made from engineered biomaterials [1,2]. Some of the most promising biomaterials for application in bone tissue engineering are bioceramics such as hydroxyapatite (HA), calcium phosphates, bioactive glasses and related composite materials combining bioactive inorganic materials with biodegradable polymers [3,4]. Bioactive inorganic materials are capable of reacting with physiological fluids forming tenacious bonds to bone through the formation of bone-like hydroxyapatite layers leading to effective biological interaction and fixation of bone tissue with the material surface [5,6]. Moreover, in the case of silicate bioactive glasses, such as 45S5 Bioglass® [5], reactions on the material surface induce the release and exchange of critical concentrations of soluble Si, Ca, P and Na ions, which can lead to favorable intracellular and extracellular responses promoting rapid bone formation [7,8,9,10,11]. In 1969, Hench and colleagues discovered that rat bone can bond chemically to certain silicate-based glass compositions [8,9]. This group of glasses was later termed “bioactive”, being “a material that elicits a specific biological response at the material surface which results in the formation of a bond between the tissues and the materials” [9,12]. Hench [8] has recently published the history leading to the development of bioactive glass (BG) focusing on the breakthrough discovery of the classical 45S5 Bioglass® composition to successful clinical applications and tissue engineering. This oldest BG composition consists of a silicate network (45 wt % SiO2) incorporating 24.5 wt % Na2O, 24.5 wt % CaO and 6 wt % P2O5 as network modifiers. The high amounts of Na2O and CaO, as well as the relatively high CaO/P2O5 ratio make the glass surface highly reactive in physiological environments [11]. Other bioactive glass compositions developed over the years contain no sodium or have additional elements incorporated in the silicate network such as fluorine [13], magnesium [14,15], strontium [16,17,18], iron [19], silver [20,21,22,23], boron [24,25,26,27], potassium [28] or zinc [29,30]. Fabrication techniques for bioactive glasses include both traditional melting methods and sol-gel techniques [1,3,4,10,31,32,33], the latter are being highlighted elsewhere [34] and are not covered in this review. The typical feature common to all bioactive glasses, being melt or sol-gel derived, is the ability to interact with living tissue, in particular forming strong bonds to bone (and in some cases soft tissue [35,36], a property commonly termed bioreactivity or bioactivity [1], as mentioned above. It is now widely accepted that for establishing bond with bone, such a biologically active apatite surface layer must form at the material/bone interface [1,8,11,12,37] (see also discussion in §4). Thus, the basis of the bone bonding property of bioactive glasses is the chemical reactivity in physiological body fluids (in vitro and in vivo) resulting in the formation of a hydroxycarbonate apatite (HCA) layer to which bone can bond. This bonding to living bone tissue occurs upon a sequence of reactions on the material surface [9] followed by cellular reactions [5], both of which are explained in detail elsewhere [1,5,9,11,12]. Briefly, the processes on the glass surface are characterized by ion leaching/exchange, dissolution of the glass network and precipitation and growth of a calcium-deficient carbonated apatite (HCA) surface layer, whereas cellular reactions include colonization, proliferation and differentiation of relevant (bone) cells [11,12] (Figure 1). In parallel to the chemical reactions on the material surface leading to bone bonding, recent studies have proven that ion dissolution and release from BG activate gene expression in osteo-genitor cells that give rise to enhanced bone regeneration (see §4.1). [Figure: Sequence of interfacial reactions involved in forming a bond between bone and a bioactive glass (modified after reference [5]).] The development of such a bioactive apatite layer is the common characteristic of all known inorganic materials used for bone replacement, orthopedic implants and bone tissue engineering scaffolds [1,38]. Early clinical applications of bioactive glasses were in the form of solid pieces for small bone replacement, i.e., in middle ear surgery [1,8,11]. Later, other clinical applications of bioactive glasses were proposed, for example in periodontology or as coating on metallic orthopedic implants [5,8]. Historically, the main function of biomaterials and implants has been to replace diseased or damaged tissues. During the past three decades, however, the strategy in biomaterial research began to shift from developing biomaterials with a bio-inert tissue response to producing bioactive components that could elicit a controlled action and reaction in the physiological environment [1]. Since the late 1990’s and the beginning of the new millennium, great potential has been attributed to the application of bioactive glasses in tissue engineering and regenerative medicine [39,40,41,42,43]. Bone tissue engineering is one of the most exciting future clinical applications of bioactive glasses. Both micron-sized and recently nanoscale particles [23,44,45] are considered in this application field, which includes also the fabrication of composite materials, e.g., combination of biodegradable polymers and bioactive glass [38,46,47,48,49,50], as discussed in detail in §3.2. Bioactive silicate glasses exhibit several advantages in comparison to other bioactive ceramics, e.g., sintered hydroxyapatite, in tissue engineering applications. For example, it has been demonstrated that dissolution products from bioactive glasses up-regulate the expression of genes that control osteogenesis [7,51], which explains the higher rate of bone formation in comparison to other inorganic ceramics such as hydroxyapatite [52]. Further studies using 45S5 Bioglass® particles have shown encouraging results regarding potential angiogenic effects of Bioglass®, i.e., increased secretion of vascular endothelial growth factor (VEGF) and VEGF gene expression in vitro, as well as enhancement of vascularization in vivo [53,54,55,56] (see §4). In addition, the incorporation of particular ions into the silicate network, such as silver [20,21,22] and boron [26,27], has been investigated in order to develop antibacterial and antimicrobial materials. Bioactive glasses can also serve as vehicle for the local delivery of selected ions being able to control specific cell functions [30,57,58,59,60,61,62,63,64]. For example, mesoporous BG microspheres have demonstrated enhanced haemostatic activity, as well as reduced clot detection times and increased coagulation rates compared to nonporous microspheres [65]. The release of calcium ions is believed to be responsible for its haemostatic properties [65]. Moreover, ferromagnetic bioactive glasses and glass-ceramics containing magnetite are being currently developed for hyperthermia treatment of

Read the complete text